CAFs also exhibit the capacity to disrupt NK function either by abolishing production of cytotoxic granules, granzyme B and perforin by PGE2 and IDO, or by secretion of MMPs to cleave NKG2D ligands on target tumour cells [286, 287, 288]. This evidence concerns the gene IDO1 and neoplasm.